Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006 Fulltext Access 8 Pages 2009
Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reaction Fulltext Access 8 Pages 2009
Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin Fulltext Access 8 Pages 2009
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys Fulltext Access 8 Pages 2009
Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis Fulltext Access 8 Pages 2009
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe Fulltext Access 8 Pages 2009
Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines Fulltext Access 8 Pages 2009
Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection Fulltext Access 8 Pages 2009
Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats Fulltext Access 8 Pages 2009
Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells Fulltext Access 8 Pages 2009
New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection Fulltext Access 8 Pages 2009
Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients Fulltext Access 8 Pages 2009
Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members Fulltext Access 8 Pages 2009
Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs Fulltext Access 8 Pages 2009
Unintended vaccination of pregnant adolescents: Estimating the scope of the problem and the impact of different pregnancy testing strategies Fulltext Access 8 Pages 2009
Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas Fulltext Access 8 Pages 2009
Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1) Fulltext Access 8 Pages 2009
Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults Fulltext Access 8 Pages 2009
A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK Fulltext Access 8 Pages 2009
Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine Fulltext Access 8 Pages 2009
Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice Fulltext Access 8 Pages 2009
Priorities in research and development of vaccines against Plasmodium vivax malaria Fulltext Access 8 Pages 2009
Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant Fulltext Access 8 Pages 2009
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity Fulltext Access 8 Pages 2009
Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants Fulltext Access 8 Pages 2009
Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond Fulltext Access 8 Pages 2009
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity Fulltext Access 8 Pages 2009
Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine Fulltext Access 8 Pages 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial Fulltext Access 8 Pages 2009
The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid Fulltext Access 8 Pages 2009
Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease Fulltext Access 8 Pages 2009
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice Fulltext Access 8 Pages 2009
Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets Fulltext Access 8 Pages 2009
Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM197 conjugate vaccine co-localizes with MHC II on the antigen processing cell surface Fulltext Access 8 Pages 2009
Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins Fulltext Access 8 Pages 2009
Challenges in the evaluation and licensing of new pneumococcal vaccines, 7–8 July 2008, Ottawa, Canada Fulltext Access 8 Pages 2009
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2007 Fulltext Access 8 Pages 2009
Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin Fulltext Access 8 Pages 2009
Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count Fulltext Access 8 Pages 2009
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity Fulltext Access 8 Pages 2009
Development and use of SIV-based Integrase defective lentiviral vector for immunization Fulltext Access 8 Pages 2009
Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model Fulltext Access 8 Pages 2009
Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages Fulltext Access 8 Pages 2009
Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination Fulltext Access 8 Pages 2009
Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells Fulltext Access 8 Pages 2009
Construction and evaluation of DNA vaccines encoding Edwardsiella tarda antigens Fulltext Access 8 Pages 2009
Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro Fulltext Access 8 Pages 2009
Schistosoma mansoni ex vivo lung-stage larvae excretory–secretory antigens as vaccine candidates against schistosomiasis Fulltext Access 8 Pages 2009
Implementation of the Australian HPV vaccination program for adult women: Qualitative key informant interviews Fulltext Access 8 Pages 2009
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response Fulltext Access 8 Pages 2009
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence Fulltext Access 8 Pages 2009
A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children Fulltext Access 8 Pages 2009
Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response Fulltext Access 8 Pages 2009
An in vivo protective response against toxic effects of the dermonecrotic protein from Loxoscelesintermedia spider venom elicited by synthetic epitopes Fulltext Access 8 Pages 2009
Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry Fulltext Access 8 Pages 2009
Th1-type epitopes-based cocktail PDDV attenuates hepatic fibrosis in C57BL/6 mice with chronic Schistosoma japonicum infection Fulltext Access 8 Pages 2009
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age Fulltext Access 8 Pages 2009
Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen Fulltext Access 8 Pages 2009
Protein prime–peptide boost as a new strategy induced an Eppin dominant B-cell epitope specific immune response and suppressed fertility Fulltext Access 8 Pages 2009
Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults Fulltext Access 8 Pages 2009
The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap Fulltext Access 8 Pages 2009
Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence Fulltext Access 8 Pages 2009
Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008–2009 conventional influenza vaccine Fulltext Access 8 Pages 2009
Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector Fulltext Access 8 Pages 2009
Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods Fulltext Access 8 Pages 2009
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3 Fulltext Access 8 Pages 2009
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen Fulltext Access 8 Pages 2009
Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants Fulltext Access 8 Pages 2009
Exosomes are an effective vaccine against congenital toxoplasmosis in mice Fulltext Access 8 Pages 2009
Rational design and immunogenicity of liposome-based diepitope constructs: Application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen Fulltext Access 8 Pages 2009
Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope Fulltext Access 8 Pages 2009
Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonellaenterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica Fulltext Access 8 Pages 2009
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine Fulltext Access 8 Pages 2009
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice Fulltext Access 8 Pages 2009
Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees Fulltext Access 8 Pages 2009
CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation Fulltext Access 8 Pages 2009
Development of a simple and high-yielding fed-batch process for the production of influenza vaccines Fulltext Access 8 Pages 2009
The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination Fulltext Access 8 Pages 2009
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model Fulltext Access 8 Pages 2009
sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria Fulltext Access 8 Pages 2009
Characterization of a concealed antigen Hq05 from the hard tick Haemaphysalis qinghaiensis and its effect as a vaccine against tick infestation in sheep Fulltext Access 8 Pages 2009
Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice Fulltext Access 8 Pages 2009
Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis Fulltext Access 8 Pages 2009
Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine Fulltext Access 8 Pages 2009
Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein Fulltext Access 8 Pages 2009
Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice Fulltext Access 8 Pages 2009
Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States Fulltext Access 8 Pages 2009
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination Fulltext Access 8 Pages 2009
DNAhsp65 vaccination induces protection in mice against Paracoccidioides brasiliensis infection Fulltext Access 8 Pages 2009
The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis Fulltext Access 8 Pages 2009
Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates Fulltext Access 8 Pages 2009